BioSpace News Archive

Rockwell Medical, Inc. announced that the Company and five members of the Rockwell Medical Board of Directors have entered into a settlement agreement with Robert Chioini, Thomas Klema, Patrick Bagley and Ronald Boyd.

Space 2.0 Pioneer BridgeSat’s Leadership Expansion Promotes Company’s Growth and Development

Presentation scheduled for 9:10 a.m. ET on August 15, 2018

Received a Complete Response Letter (“CRL”) from the United States Food and Drug Administration (“FDA”) regarding the New Drug Application (“NDA”) for TLANDO™, the Company’s oral testosterone product candidate for testosterone replacement therapy (“TRT”) in adult males for conditions associated with a deficiency of endogenous testosterone, also known as hypogonadism.

Plan to Open Expansion Cohorts in Phase 1 Trial of SY-1365 in Fall of 2018; Expansion to Focus on Ovarian and Breast Cancer Patient Populations as Single Agent and in Combination

Conditional acceptance granted by U.S. Food and Drug Administration (FDA) for the proprietary name ZULRESSO™ for Sage’s intravenous formulation of brexanolone

Aerpio Pharmaceuticals, Inc. announced that its second quarter 2018 financial results will be released before the market opens on Tuesday, August 14, 2018.

Hondros College of Nursing (HCN) will welcome students to its new program in Medical Laboratory Technology for the first time in October 2018.

Eiger BioPharmaceuticals, Inc. announced that David Cory, President and CEO, will present a corporate update at the 2018 Wedbush PacGrow Healthcare Conference on August 15 at 2:30 PM ET.

Envoy Medical Corporation has announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for the Esteem® Hearing Implant